Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease

Neurobiology of Aging

Volumn 31, Issue 10, 2010, Pages 1669-1678

  Braskie, Meredith N ^a,b   Klunder, Andrea D ^b   Hayashi, Kiralee M ^b   Protas, Hillary ^b   Kepe, Vladimir ^b   Miller, Karen J ^b   Huang, S C ^b   Barrio, Jorge R ^b   Ercoli, Linda M ^b   Siddarth, Prabha ^b   Satyamurthy, Nagichettiar ^b   Liu, Jie ^b   Toga, Arthur W ^b   Bookheimer, Susan Y ^b   Small, Gary W ^b,c   Thompson, Paul M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyloid; Cerebral cortex; Cognitive aging; Memory; PET

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; FRONTAL CORTEX; HUMAN; INTERMETHOD COMPARISON; MALE; MENTAL PERFORMANCE; MILD COGNITIVE IMPAIRMENT; NEUROFIBRILLARY TANGLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; SENILE PLAQUE; TEMPORAL CORTEX;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; CEREBRAL CORTEX; COGNITION; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; PLAQUE, AMYLOID; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 77955846423     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.09.012     Document Type: Article

References (42)

1. Agdeppa E.D., Kepe V., Liu J., Flores-Torres S., Satyamurthy N., Petric A., Cole G.M., Small G.W., Huang S.C., Barrio J.R. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. J. Neurosci. 2001, 21:RC189.
2. Agdeppa E.D., Kepe V., Shoghi-Jadid K., Satyamurthy N., Small G.W., Petric A., Vinters H.V., Huang S.-C., Barrio J.R. In vivo and in vitro labeling of plaques and tangles in the brain of an Alzheimer's disease patient: a case study. Ann. Meet. J. Nuclear Med. 2001, 42(Suppl 1):65P.
3. American Psychological Association, 2000. Diagnosis and Statistical Manual of Mental Disorders DSM-IV-TR (Text Revision). Washington, DC.
4. Apostolova L.G., Lu P.H., Rogers S., Dutton R.A., Hayashi K.M., Toga A.W., Cummings J.L., Thompson P.M. 3D mapping of mini-mental state examination performance in clinical and preclinical Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2006, 20:224-231.
5. Berg L., McKeel D.W., Miller J.P., Storandt M., Rubin E.H., Morris J.C., Baty J., Coats M., Norton J., Goate A.M., Price J.L., Gearing M., Mirra S.S., Saunders A.M. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch. Neurol. 1998, 55:326-335.
6. Binder L.I., Guillozet-Bongaarts A.L., Garcia-Sierra F., Berry R.W. Tau, tangles, and Alzheimer's disease. Biochim. Biophys. Acta 2005, 1739:216-223.
7. Bouras C., Hof P.R., Giannakopoulos P., Michel J.P., Morrison J.H. Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb. Cortex 1994, 4:138-150.
8. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl) 1991, 82:239-259.
9. Braak H., Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 1997, 18:351-357.
10. Buckner R.L., Snyder A.Z., Shannon B.J., LaRossa G., Sachs R., Fotenos A.F., Sheline Y.I., Klunk W.E., Mathis C.A., Morris J.C., Mintun M.A. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci. 2005, 25:7709-7717.
11. Bullmore E.T., Suckling J., Overmeyer S., Rabe-Hesketh S., Taylor E., Brammer M.J. Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain. IEEE Trans. Med. Imag. 1999, 18:32-42.
12. Castellani R.J., Lee H.G., Perry G., Smith M.A. Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau. Am. J. Alzheimers Dis. Other Demen. 2006, 21:126-130.
13. Collins D.L., Neelin P., Peters T.M., Evans A.C. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J. Comput. Assist. Tomogr. 1994, 18:192-205.
14. Giannakopoulos P., Herrmann F.R., Bussiere T., Bouras C., Kovari E., Perl D.P., Morrison J.H., Gold G., Hof P.R. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 2003, 60:1495-1500.
15. Gomez-Isla T., Price J.L., McKeel D.W., Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 1996, 16:4491-4500.
16. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiat. 1960, 23:56-62.
17. Hayashi K.M., Thompson, P.M., Mega, M.S., Zoumalan, C.I., 2002. Medial hemispheric surface gyral pattern delineation in 3D: surface curve protocol, http://www.loni.ucla.edu/~khayashi/Public/Medial_surface/MedialLinesProtocol.
18. Jones S., Laukka E.J., Backman L. Differential verbal fluency deficits in the preclinical stages of Alzheimer's disease and vascular dementia. Cortex 2006, 42:347-355.
19. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., Bergstrom M., Savitcheva I., Huang G.F., Estrada S., Ausen B., Debnath M.L., Barletta J., Price J.C., Sandell J., Lopresti B.J., Wall A., Koivisto P., Antoni G., Mathis C.A., Langstrom B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 2004, 55:306-319.
20. Lerch J.P., Pruessner J.C., Zijdenbos A., Hampel H., Teipel S.J., Evans A.C. Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy. Cereb. Cortex 2005, 15:995-1001.
21. 18F]FDDNP) ready for animal or human administration. Mol. Imag. Biol. 2007, 9:6-16.
22. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 1996, 16:834-840.
23. MacDonald D., Kabani N., Avis D., Evans A.C. Automated 3D extraction of inner and outer surfaces of cerebral cortex from MRI. Neuroimage 2000, 12:340-356.
24. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
25. Mintun M.A., Larossa G.N., Sheline Y.I., Dence C.S., Lee S.Y., Mach R.H., Klunk W.E., Mathis C.A., DeKosky S.T., Morris J.C. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 2006, 67:446-452.
26. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 2004, 256:183-194.
27. Protas H., Thompson P.M., Hayashi K.M., Huang S.C. Cortical brain surface mapping for studying partial volume effects in brain FDG-PET images. Proceedings of the 52nd Annual Meeting of the Society for Nuclear Medicine (SNM) 2005.
28. Sapiro G. Geometric Partial Differential Equations and Image Analysis 2001, Cambridge University Press.
29. Selkoe D.J. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J. Alzheimer's Dis. 2001, 3:75-80.
30. Shattuck D.W., Sandor-Leahy S.R., Schaper K.A., Rottenberg D.A., Leahy R.M. Magnetic resonance image tissue classification using a partial volume model. Neuroimage 2001, 13:856-876.
31. Singh V., Chertkow H., Lerch J.P., Evans A.C., Dorr A.E., Kabani N.J. Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease. Brain 2006, 129:2885-2893.
32. Small G.W., Ercoli L.M., Silverman D.H., Huang S.C., Komo S., Bookheimer S.Y., Lavretsky H., Miller K., Siddarth P., Rasgon N.L., Mazziotta J.C., Saxena S., Wu H.M., Mega M.S., Cummings J.L., Saunders A.M., Pericak-Vance M.A., Roses A.D., Barrio J.R., Phelps M.E. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:6037-6042.
33. Small G.W., Kepe V., Ercoli L.M., Siddarth P., Bookheimer S.Y., Miller K.J., Lavretsky H., Burggren A.C., Cole G.M., Vinters H.V., Thompson P.M., Huang S.C., Satyamurthy N., Phelps M.E., Barrio J.R. PET of brain amyloid and tau in mild cognitive impairment. N. Engl. J. Med. 2006, 355:2652-2663.
34. Smith S.M. Fast robust automated brain extraction. Hum. Brain Mapp. 2002, 17:143-155.
35. Sowell E.R., Thompson, P.M., Mega, M.S., Zoumalan, C.I., Lindshield, C.J., Rex, D.E., 2000. Gyral pattern delineation in 3D: surface curve protocol, http://www.loni.ucla.edu/~esowell/new_sulc_var.html.
36. Sowell E.R., Thompson P.M., Leonard C.M., Welcome S.E., Kan E., Toga A.W. Longitudinal mapping of cortical thickness and brain growth in normal children. J. Neurosci. 2004, 24(38):8223-8231.
37. Tabert M.H., Manly J.J., Liu X., Pelton G.H., Rosenblum S., Jacobs M., Zamora D., Goodkind M., Bell K., Stern Y., Devanand D.P. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch. Gen. Psychiat. 2006, 63:916-924.
38. Thal D.R., Rub U., Orantes M., Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002, 58:1791-1800.
39. Thompson P.M., Hayashi K.M., de Zubicaray G., Janke A.L., Rose S.E., Semple J., Herman D., Hong M.S., Dittmer S.S., Doddrell D.M., Toga A.W. Dynamics of gray matter loss in Alzheimer's disease. J. Neurosci. 2003, 23:994-1005.
40. Thompson P.M., Hayashi K.M., Sowell E.R., Gogtay N., Giedd J.N., Rapoport J.L., de Zubicaray G.I., Janke A.L., Rose S.E., Semple J., Doddrell D.M., Wang Y., van Erp T.G., Cannon T.D., Toga A.W. Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. Neuroimage 2004, 23(Suppl 1):S2-18.
41. Verhoeff N.P., Wilson A.A., Takeshita S., Trop L., Hussey D., Singh K., Kung H.F., Kung M.P., Houle S. In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. Am. J. Geriatr. Psychiat. 2004, 12:584-595.
42. Watson D., Castano E., Kokjohn T.A., Kuo Y.M., Lyubchenko Y., Pinsky D., Connolly E.S., Esh C., Luehrs D.C., Stine W.B., Rowse L.M., Emmerling M.R., Roher A.E. Physicochemical characteristics of soluble oligomeric A beta and their pathologic role in Alzheimer's disease. Neurol. Res. 2005, 27:869-881.